We aimed to clarify the intricate relationship between modified LCAT function, HDL composition, and cardiovascular complications in the context of CKD by measuring LCAT activity and utilizing NMR measurements for comprehensive lipoprotein profiling. This evidence concerns the gene LCAT and chronic kidney disease.